ARS Pharmaceuticals (SPRY) Shareholders equity

annual shareholders equity:

$256.80M+$26.04M(+11.28%)
December 31, 2024

Summary

  • As of today (July 4, 2025), SPRY annual stockholders equity is $256.80 million, with the most recent change of +$26.04 million (+11.28%) on December 31, 2024.
  • During the last 3 years, SPRY annual shareholders equity has risen by +$288.07 million (+921.25%).
  • SPRY annual shareholders equity is now -5.90% below its all-time high of $272.89 million, reached on December 31, 2022.

Performance

SPRY Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

quarterly shareholders equity:

$228.97M-$27.82M(-10.83%)
March 31, 2025

Summary

  • As of today (July 4, 2025), SPRY quarterly stockholders equity is $228.97 million, with the most recent change of -$27.82 million (-10.83%) on March 31, 2025.
  • Over the past year, SPRY quarterly shareholders equity has increased by +$5.11 million (+2.28%).
  • SPRY quarterly shareholders equity is now -16.09% below its all-time high of $272.89 million, reached on December 31, 2022.

Performance

SPRY quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

SPRY Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+11.3%+2.3%
3 y3 years+921.3%-
5 y5 years+1927.5%+832.3%

SPRY Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-5.9%+921.3%-16.1%+620.0%
5 y5-year-5.9%+921.3%-16.1%+620.0%
alltimeall time-5.9%+921.3%-16.1%+620.0%

SPRY Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$228.97M(-10.8%)
Dec 2024
$256.80M(+11.3%)
$256.80M(+27.8%)
Sep 2024
-
$200.98M(-6.6%)
Jun 2024
-
$215.24M(-3.9%)
Mar 2024
-
$223.87M(-3.0%)
Dec 2023
$230.76M
$230.76M(-2.7%)
Sep 2023
-
$237.28M(-4.5%)
DateAnnualQuarterly
Jun 2023
-
$248.55M(-4.8%)
Mar 2023
-
$261.15M(-4.3%)
Dec 2022
$272.89M(-972.7%)
$272.89M(-719.7%)
Jun 2022
-
-$44.03M(+40.8%)
Dec 2021
-$31.27M(+122.5%)
-
Dec 2021
-
-$31.27M
Dec 2020
-$14.05M
-

FAQ

  • What is ARS Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals annual shareholders equity year-on-year change?
  • What is ARS Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals quarterly shareholders equity year-on-year change?

What is ARS Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of SPRY is $256.80M

What is the all time high annual shareholders equity for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high annual stockholders equity is $272.89M

What is ARS Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, SPRY annual stockholders equity has changed by +$26.04M (+11.28%)

What is ARS Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of SPRY is $228.97M

What is the all time high quarterly shareholders equity for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high quarterly stockholders equity is $272.89M

What is ARS Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, SPRY quarterly stockholders equity has changed by +$5.11M (+2.28%)
On this page